| Stephanie Ferrin, MD | |
|
1301 Central Dr, Sanford, NC 27330-4159 | |
| (919) 718-9512 | |
| (919) 718-9516 |
| Full Name | Stephanie Ferrin |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1301 Central Dr, Sanford, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972948438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 30055 (Oklahoma) | Primary |
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
A stem cell therapy previously shown to reduce inflammation in the critical time window after traumatic brain injury also promotes lasting cognitive improvement, according to preclinical research led by Charles Cox, M.D., at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
With a $4.7 million grant from the National Cancer Institute, the University of Chicago's Globus and leading cancer researchers at University of Chicago Medicine will build new protected cancer research networks that enable collaborations while keeping sensitive health data secure and private.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
MGC Diagnostics Corporation, a global medical technology company, today reported financial results for the fourth quarter and year ended October 31, 2013.
› Verified 1 days ago
| Entity Name | Unc Physicians Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750704367 PECOS PAC ID: 5496940546 Enrollment ID: O20101115000646 |
News Archive
A stem cell therapy previously shown to reduce inflammation in the critical time window after traumatic brain injury also promotes lasting cognitive improvement, according to preclinical research led by Charles Cox, M.D., at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
With a $4.7 million grant from the National Cancer Institute, the University of Chicago's Globus and leading cancer researchers at University of Chicago Medicine will build new protected cancer research networks that enable collaborations while keeping sensitive health data secure and private.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
MGC Diagnostics Corporation, a global medical technology company, today reported financial results for the fourth quarter and year ended October 31, 2013.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Ferrin, MD 2000 Perimeter Park Dr Ste 200, Morrisville, NC 27560-8442 Ph: () - | Stephanie Ferrin, MD 1301 Central Dr, Sanford, NC 27330-4159 Ph: (919) 718-9512 |
News Archive
A stem cell therapy previously shown to reduce inflammation in the critical time window after traumatic brain injury also promotes lasting cognitive improvement, according to preclinical research led by Charles Cox, M.D., at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
With a $4.7 million grant from the National Cancer Institute, the University of Chicago's Globus and leading cancer researchers at University of Chicago Medicine will build new protected cancer research networks that enable collaborations while keeping sensitive health data secure and private.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
MGC Diagnostics Corporation, a global medical technology company, today reported financial results for the fourth quarter and year ended October 31, 2013.
› Verified 1 days ago
Janice E Aton, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1688 S Horner Blvd, Sanford, NC 27330 Phone: 919-775-7337 Fax: 919-775-1525 | |
John B. Hipps, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Central Dr, Sanford, NC 27330 Phone: 919-718-9512 Fax: 919-718-9516 | |
Dr. Allison Jane Burbank, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Central Dr, Sanford, NC 27330 Phone: 919-718-9512 Fax: 919-718-9516 | |
Nina Jain, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Central Dr, Sanford, NC 27330 Phone: 919-718-9512 Fax: 919-718-9516 | |
Dr. Aliese Anahid Sarkissian, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Central Dr, Sanford, NC 27330 Phone: 919-718-9512 Fax: 919-718-9516 | |
Rebecca A. Baum, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Central Dr, Sanford, NC 27330 Phone: 919-718-9512 Fax: 919-718-9516 | |
Tiffany Jones Petty, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1801 Doctors Dr, Sanford, NC 27330 Phone: 919-774-7117 Fax: 919-776-6715 |